Get This 21 CENT Crypto for a Crypto Rebound

Legendary crypto expert Charlie Shrem is urging folks to grab shares of a little-known crypto that currently trades for just $0.21 right now. He believes it could easily become a TOP FIVE Coin... and ultimately become the big winner of 2022.

In Psychedelic Investing, Long-Term Thinking Is Key

Microdose Psychedelic Insights
August 13, 2022

This article was originally published on Microdose and appears here with permission. 

In response to a worldwide mental illness epidemic and flood of capital from investing firms, the psychedelic industry has seen explosive growth in recent years.

The newfound enthusiasm is advancing rapidly in the U.S. and worldwide. The sector broke new ground last year as states such as Utah, Missouri, Connecticut, New Jersey, Texas and California took essential steps to decriminalize or legalize psychedelic substances. On the commercial side, Data Bridge Market Research estimates that the psychedelic market in the U.S. could total $9.8 billion by 2029. That growth opportunity has spawned a long list of startups and a wave of psychedelic-related mergers and acquisitions involving investing holdings, media organizations, research, and other areas.

A recent example is Blackhawk Growth, a Vancouver-based investment firm, announcing a share purchase agreement, acquiring control of MindBio Therapeutics.

“The acquisition of MindBio Therapeutics will help to scale our life science and psychedelic portfolio,” said Frederick Pels, CEO of Blackhawk. “Complementing our current assets, a clinical trial and a management team with decades of experience in the health sector will enable Blackhawk and MindBio Therapeutics to be leaders in the legal psychedelic treatment industry that we believe will only continue to grow exponentially.”

MindBio Therapeutics is an arms-length privately-held clinical-stage drug development company pioneering psychedelic microdosing research and exploring emerging therapies to treat various mental health conditions such as depression, anxiety, chronic pain and PTSD.

“We are excited to become part of the Blackhawk portfolio, which expands our investor reach to the capital markets in North America, and we are now truly a global company with connections in Australia, New Zealand and Canada,” says Justin Hanka, Director of MindBio Therapeutics. “This is an important step in terms of accelerating our clinical research micro-dosing psychedelic medicines in Phase 2 clinical trials and the next steps towards commercialization.”

MindBio

Mindbio’s Justin Hanka at Plant Medicine Week

According to a study by The Lancet, the global pandemic has severely harmed people’s mental health, with over 53 million additional major cases of depressive disorder and 76 million instances of anxiety disorders globally. Conversely, a recent report by Global Industry Analysts estimates that treatments for depression will comprise the most significant chunk of the disease indication segment, with more than 40% market share by the end of 2021.

The recognition of the enormous potential to use psychedelics for mental illness has driven substantial investment in the sector in the past four years. Companies are aiming to control and harness these drugs’ mood-altering capabilities. Similar to cannabis legalization, different jurisdictions are slowly opening their minds to experimenting with these drugs for medical uses.

“The pandemic and unfortunate rise in mental health-related complications has proved to be a real tailwind for the psychedelics space,” says Ken Ken Belotsky, Partner at Negev Capital, an investment firm focused on companies developing novel psychedelic medications for various mental health issues. “The focus on mental health has created a much larger addressable market as investors recognize that psychedelics can transform the broader mental health market.”

However, Belotsky highlights the risks involved in the psychedelic investment landscape and urges responsibility, analytical research, and patience on the part of anyone considering investing. Indeed, he believes only the companies with strong management teams will survive the current market downturn and emerge as winners when all the dust settles.

“The key is getting to know the players and gaining a deep understanding of the business and the management team,” Belotsky explains. “We have a responsibility to our investors to provide outstanding capital returns. That’s why, at Negev capital, we are approaching all our investments and partnerships with a long-term view.”

After receiving a post-IPO run-up valuation of $1.1 billion, Compass Pathways announced that it had completed the first randomized, double-blind trial of psilocybin for treating depressive symptoms, given to 233 patients across Europe and North America. Biotech company, Enveric Biosciences has developed a robust pipeline to move the company from the discovery phase to clinical development. “Enveric platform has the potential to disrupt and unlock much needed mental health treatments through psychedelic therapies,” says Dr. Joseph Tucker, CEO of Enveric.

As psychedelic medicine and therapy gain a foothold, researchers, activists, and members of the psychedelic community are calling for embracing innovative new business strategies to support the creation of a new kind of healthcare industry—one that addresses the inadequacy of traditional mental healthcare approach that’s made little progress in novel treatments over half a century.

“The perception has changed very quickly regarding entrepreneurship interest in psychedelics,” said Connor Haslam, CEO of Microdose Psychedelic Insights, a media company focused on building bridges and fostering communities while educating new investors. “And naturally that has helped increase interest from the public, policymakers, scientists and researchers to think about different structures and pathways of solving the mental health crisis.”

Meanwhile, at the World Economic Forum in Davos, psychedelics potential was a big part of the conversation among the participants for the first time.

“I am a firm believer that psychedelics have the ability to unlock novel approaches to disorders notoriously difficult to treat, like PTSD, alcoholism, opioid addiction and pain,” Kevin McKenzie, co-founder of Carvin Medicines, a Swiss drug company entering the psychedelic drug market told the Guardian. “Hosting this in Davos at the same location as WEF is a genius strategy – it brings fresh eyes and bright minds to psychedelic drug development, which builds credibility for these medicines,” he said.

As more companies aim to harness these drugs’ mood-altering capabilities, different jurisdictions are slowly opening their minds to experimenting with them for medical use. Lengthy regulatory processes and inefficiency within the healthcare industry will undoubtedly hinder market growth in the short term. And decades of entrenched stigma, long medical trials, and scarcity in funding during market volatility will certainly test the resiliency of this emerging space.

But, as Belotsky puts it, “for those long-term investors who have vetted the companies diligently and familiarize themselves properly with the industry, the potential is limitless. You should fear the market downturn if you expect massive gains in the short term without doing your homework.”

Continue Reading...

Most Popular
September 29, 2022

Check Out What Whales Are Doing With AMT

Someone with a lot of money to spend has taken a bearish stance on American Tower (NYSE:AMT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

September 29, 2022

Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 930 stocks hit new 52-week lows.

September 30, 2022

Big News: JPMorgan Predicts $130K Bitcoin! - Ad

JPMorgan says Bitcoin could hit $130,000. Ex-Goldman Sachs executive Raoul Pal seems to think that's way too low. And Ark Invest -- expects Bitcoin's total market cap to surpass gold's. These Wall Street titans are bullish for the exact same reasons we've been telling you about for months now...

September 29, 2022

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

September 30, 2022

10 Information Technology Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

September 30, 2022

How Randell Turns $250 Into $1,500 Each Day - Ad

On the training, you will learn about the... "Window Of Opportunity - 7 Ways To Make Money With Crypto Even If You Are Brand New" plus a bonus 8th "Instant Money Loophole" strategy you can start today.

September 29, 2022

Why Kevin O'Leary, Jordan Belfort Welcome Crypto Regulation

Perhaps a bear market is really a time to grow, even if you aren’t a billionaire adding to your holdings. 

September 30, 2022

Legal Crypto Loophole - Ad

On the training, you will learn about the... "Window Of Opportunity - 7 Ways To Make Money With Crypto Even If You Are Brand New" plus a bonus 8th "Instant Money Loophole" strategy you can start today.

September 29, 2022

Apple To Rally Around 30%? Here Are 5 Other Price Target Changes For Thursday

Rosenblatt raised Apple Inc. (NASDAQ: AAPL) price target from $160 to $189. Rosenblatt analyst Barton Crockett also upgraded the stock from Neutral to Buy. Apple shares fell 2.3% to $146.33 in pre-market trading.

September 29, 2022

Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China

Merck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19 antiviral pills, which were co-developed by Ridgeback Therapeutics. 

September 30, 2022

How Artificial Intelligence Could Change the Way You Think About Investing - Ad

Firms like Goldman Sachs, BlackRock, and JP Morgan are using it to gain a valuable edge in the market. Louis put the finishing touches on an AI-powered quant-based system with the goal of revolutionizing the way you and I play the stock market.

September 28, 2022

Trump Lawyers Make Move To Swiftly End Journalist's Rape-Related Defamation Lawsuit

Donald Trump is reportedly pursuing a swift end to a defamation lawsuit brought by a journalist who claims the former president raped her. 

September 30, 2022

"Odd" Investment Nearly Doubles the Market? - Ad

"I just don't believe it" -- That's what most people would say about a 114.5% total return from less than 9 minutes of "work." But investing icon Jim Fink has defied Wall Street time and time again thanks to the incredible precision and power of his "odd" system...

September 29, 2022

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

Gainers Shift Technologies (NASDAQ:SFT) shares increased by 5.0% to $0.69 during Thursday's after-market session. The market value of their outstanding shares is at $58.8 million.

September 30, 2022

MetLife Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on MetLife (NYSE:MET). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

September 30, 2022

ALERT: Sell These Four Funds Today - Ad

If you own funds from Fidelity, iShares, or Franklin Templeton, you may have a ticking time bomb sitting in your portfolio. Read this urgent briefing to see why this could set your retirement back ten years!

September 30, 2022

Day After Biden's Gaffe, VP Harris Hails 'Important Relationship' With Kim Jong Un's North Korea

Vice president Kamala Harris in a verbal gaffe, touted the strong alliance between the U.S. and “the Republic of North Korea,” while addressing the audience in Korean Demilitarized Zone.

September 28, 2022

Expert Ratings for Magna International

Magna International (NYSE:MGA) has observed the following analyst ratings within the last quarter:

September 30, 2022

Why Is "The Godfather of Crypto" Marking his Calendar for October 18th? - Ad

Legendary crypto expert Charlie Shrem is urging folks to grab shares of a little-known crypto that currently trades for just $0.21 right now. He believes it could easily become a TOP FIVE Coin... and ultimately become the big winner of 2022.

September 30, 2022

What 6 Analyst Ratings Have To Say About Rocket Companies

Within the last quarter, Rocket Companies (NYSE:RKT) has observed the following analyst ratings:

September 30, 2022

248 Apple Car patents and counting -- grab this stock for $5 while you can! - Ad

An Apple EV is in the works, and it could change transportation as we know it. And while I don't think it's a bad idea to swipe up some Apple stocks right now... There's a better opportunity lying under Wall Street's radar... a $5 stock that my research indicates has the potential to 40X once the Apple Car goes live.

September 30, 2022

Japan Beefs Up Semiconductor Presence By Tying Up With Several Chipmakers, Latest Being Micron

Japanese government committed subsidies of up to $320 million to U.S. chipmaker Micron Technology, Inc (NASDAQ: MU) to fortify supply chains against China.

September 30, 2022

3 Reasons Why... (This Is THE ONE) - Ad

Right now only the savviest scientists and investors know about this... But that's starting to change. If you were to make only one investment in the next decade, this is it.

September 29, 2022

Recap: Rite Aid Q2 Earnings

Rite Aid (NYSE:RAD) reported its Q2 earnings results on Thursday, September 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Rite Aid missed estimated earnings by 14.55%, reporting an EPS of $-0.63 versus an estimate of $-0.55.

September 30, 2022

Thai Court Paves Way From PM Prayuth To Return To Office After Five-Week Suspension

Thailand’s Constitutional Court on Friday ruled that Prime Minister Prayuth Chan Ocha can remain in his job, paving the way for him to return to office after a five-week suspension. What Happened: The court said Prayuth did not violate a constitutional provision limiting him to eight years in Thailand’s top office.

September 30, 2022

Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast - Ad

He predicted the 2020 crash a month before it happened... He predicted this year's collapse back in January... And now, he's issuing a brand-new warning -- along with a unique solution.

September 30, 2022

Jim Belushi's Farm Products Launch In Nevada Via Partnership With Jade Cannabis

Jade Cannabis Co. will celebrate its new partnership with Belushi’s Farm by hosting a celebrity meet-and-greet with farmer, actor, comedian and musician Jim Belushi on October 2, 2022 from 11:00 AM to 2:00 PM at 1085 S. Virginia Street, Suite A in Midtown Reno.

September 28, 2022

Elon Musk Throws Shade At Henrik Fisker Over Something He Did To Tesla 15 Years Ago: 'Karma Is A ...'

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has thrown more fuel on his fiery rivalry with Fisker Inc (NYSE: FSR) CEO Henrik Fisker.

September 30, 2022

How to Buy the Hottest Cryptos at a Discount - Ad

For the opportunity to build the kind of monumental wealth that early Bitcoin investors have created... You need to explore a sector of the crypto world that almost no one has ever heard of -- a small group of new, under the radar digital currencies that could soon burst out of the digital shadows.

September 29, 2022

Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme

U.S. District Judge Ann Donnelly has ordered to freeze several assets related to people and entities accused of operating a U.S. supply chain that distributes counterfeit bottles of Gilead Sciences Inc's (NASDAQ: GILD) HIV drugs.

September 30, 2022

This Tuesday: 6-Minute Crypto Loophole Brings In $500 A Day (Even For Beginners) - Ad

In just a few days, crypto millionaire Scott Phillips will reveal how you can bring in $500-$2k a day with crypto. Without yield farming, bots, mining, or investing in longshot coins.His method CRUSHED while the crypto market was crashing... and when the market was mooning.

September 29, 2022

Four Times Elon Musk Has Tried To Play Savior During Disasters

Elon Musk has a knack for portraying himself as a hero in times of crisis. Today, the Tesla Inc (NASDAQ: TSLA) CEO tweeted amid the ongoing floods and hurricane damage in Florida that Cybertrucks can “briefly serve as a boat.”

September 30, 2022

Russian Missile Attack Kills 23 Civilians In Ukraine Hours Before Putin's Annexation Speech: Official

Ukraine's regional governor said a Russian missile slammed on a convoy of cars in southern Ukraine on Friday, killing a number of civilians, hours ahead of President Vladimir Putin's annexation ceremony. 

September 30, 2022

The Crypto Story Bigger than Bitcoin - Ad

We cover a short list of new cryptos that have the best potential to be the next Bitcoins, collectively creating greater wealth for investors than Bitcoin ever has, or probably ever will.

September 29, 2022

These 2 High Yielders Could Benefit From The Supply Crunch Caused By The Russia-Ukraine War

Since the Energy Select Sector SPDR FUN (ARCA: XLE) is down roughly 16% over the past month, it may be a good time to shop around for oversold equities in the oil and gas sector. Although investors are concerned about a recession slowing down the economy, natural gas prices are still at record highs.

Most Recent
September 30, 2022

(STOP) Buy This Instead of EV Stocks - Ad

September 30, 2022

The Pre-IPO Cheat Code Project - Ad

September 30, 2022

MetLife Whale Trades Spotted

September 30, 2022

Retirement Checks Every Day? - Ad

September 30, 2022

Recap: Circor Intl Q2 Earnings

September 30, 2022

Crypto Expert Reveals Next Trade - Ad

September 30, 2022

Do NOT buy crypto until you see this! - Ad

September 30, 2022

Watch Charlie Shrem's Next Trade - Ad

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright 2020 activatrade.ca
Privacy Policy | Terms of Service